Biocardia reports second quarter 2021 financial results and business highlights

San carlos, calif., aug. 12, 2021 (globe newswire) -- biocardia, inc. [nasdaq: bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the second quarter of 2021 and filed its quarterly report on form 10-q for the three and six months ended june 30, 2021 with the securities and exchange commission.
BCDA Ratings Summary
BCDA Quant Ranking